Over the past twenty five years our
trial lawyers have prosecuted and defended dozens of complex criminal
and civil fraud cases in health care, defense contracting, tax,
securities and other industries.
For decades, prescription drug
makers have consistently been among the most profitable industries in America.
While pharmaceutical companies become richer, consumers and payors are paying
higher costs for prescription drugs. This overwhelming and dramatic rise
in prescription drug prices has spurred several consumer interest organizations
representing sections to root out collusive and profit-driven schemes within
the drug industry.
KEMY is at the forefront of legal efforts
to effectively battle unlawful activities that have caused healthcare
costs to skyrocket in recent years. KEMY has been retained
by both individuals and third-party payors to put a stop to pharmaceutical
companies' distribution of defective medical devices and drugs, unlawful
price inflation, filing of false secondary patents that block competitive
generic drugs, and drug promotion for uses not approved by the Food
and Drug Administration, commonly known as "off-label" uses.
Kenney Egan McCafferty & Young, P.C., ("KEMY"), only provides legal advice after having entered into an attorney-client relationship, which our website specifically does not create. Only after having entered into a written, signed agreement with KEMY is an attorney-client relationship created. Any electronic communication sent to KEMY may not be secure, and thus may be disclosed. Accordingly, we request that you do not send sensitive or confidential information electronically. In addition, the sending of electronic mail to any lawyer or other address identified in this website does not create a lawyer-client relationship. The contents of any such mail are not privileged, unless the sender is a current client of KEMY, and the communication is sent pursuant to that attorney-client relationship.
